NCT05979870View on ClinicalTrials.gov

Artificial Intelligence in New Cardiac MR Markers for Congenital Heart Disease

Enrolling by invitationOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Aortic Valve DiseasePulmonary Valve DiseaseChild, OnlyMagnetic Resonance ImagingRisk Stratification
Interventions
PROCEDURE

Valvuloplasty,

Choice of type of intervention decided on a multidisciplinary conference

Trial Locations (1)

41560

Queen Silvia Children'sHospital, Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
lead

Sahlgrenska University Hospital

OTHER